The #1 Plant Based Food and Wellness Magazine in the United States to Feature Tauri-Gum in its March/April 2020 Edition
February 03 2020 - 8:20AM
InvestorsHub NewsWire
The #1 Plant Based Food and
Wellness Magazine in the United States to Feature Tauri-Gum in its
March/April 2020 Edition
Magazine has a Readership of 970,000 and is
Available at all Major U.S. Grocery Store
Chains
NEW YORK, NY -- February 3, 2020 --
InvestorsHub NewsWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating company that
operates through the development, distribution, and licensing of
proprietary products as well as the evaluation of potential
acquisition opportunities and equity investments, today announced
that Thrive Magazine (“Thrive”), the #1 plant based food and
wellness magazine in the United States (“U.S.”), will feature
Tauri-Gum™ in its March/April 2020 Edition. Thrive has a
readership of 970,000 and is available at all major U.S. grocery
store chains, including: Whole Foods Market, Target, Sprouts,
Earthfare, Meijer, Kroger, Publix, Albertsons, HEB, Hy-Vee,
Walmart, Costco, as well as many other stores
nationwide.
Thrive Magazine
Website:
Link: https://www.mythrivemag.com
ABOUT TAURIGA SCIENCES,
INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating company that operates through the
development, distribution, and licensing of proprietary products as
well as the evaluation of potential acquisition opportunities. One
such opportunity on which the Company has acted, involves the
Company having entered into the cannabidiol (or “CBD”) infused
chewing gum product business, as more fully described above and in
prior press releases. This CBD infused chewing gum product
has been branded under the following name:
Tauri-Gum™. The Company is currently in production of
three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and
POMEGRANATE. On December 6, 2019 the Company announced
that it completed the initial production run (thereby expanding its
existing product lines) with the introduction of a 25mg Vegan CBD
Isolate Infused vegan gummy (“gum drop”), branded under the name:
Tauri-Gummies™. Further, the Company continues to
identify and evaluate additional potential opportunities to
generate revenue, as well as shareholder value, and leverage its
resources and expertise to build a diversified and sustainable
business model. Please visit our corporate website at www.tauriga.com.
The Company has also announced the development of a
Cannabigerol (“CBG”) Isolate infused version of
Tauri-Gum™. The flavor that has been selected is
Starfruit/Peach and each piece of gum will contain 10mg of CBG
Isolate / Each blister pack will contain 80mg of CBG
Isolate. The Company expects to commence production during its
4thFiscal Quarter of 2020 (January 1, 2020 – March 31,
2020).
In addition, on March 11, 2019, the Company
announced the official launch of its E-Commerce site - as part of
its Tauri-Gum™ commercialization strategy. This site can be
accessed by visiting the following URL
address: www.taurigum.com
The Company has established corporate offices in
both New York City (USA) and Barcelona
(Spain).
DISCLAIMER -- Forward-Looking
Statements
This press release contains certain
“forward-looking statements” as defined by the Private Securities
Litigation Reform Act of 1995 which represent management’s beliefs
and assumptions concerning future events. These forward-looking
statements are often indicated by using words such as “may,”
“will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or
plans, and may include statements regarding corporate objectives as
well as the attainment of certain corporate goals and milestones.
Forward-looking statements are based on present circumstances and
on management’s present beliefs with respect to events that have
not occurred, that may not occur, or that may occur with different
consequences or timing than those now assumed or anticipated.
Actual results may differ materially from those expressed in
forward-looking statements due to known and unknown risks and
uncertainties, such as are not guarantees of general economic and
business conditions, the ability to successfully develop and market
products, consumer and business consumption habits, the ability to
consummate successful acquisition and licensing transactions,
fluctuations in exchange rates, and other factors over which
Tauriga has little or no control. Many of these risks and
uncertainties are discussed in greater detail in the “Risk Factors”
section of Tauriga’s Form 10-K and other filings made from time to
time with the Securities and Exchange Commission. Such
forward-looking statements are made only as of the date of this
release, and Tauriga assumes no obligation to update
forward-looking statements to reflect subsequent events or
circumstances. You should not place undue reliance on these
forward-looking statements.
CONTACT INFORMATION
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024